Previous Close | 111.23 |
Open | 112.39 |
Bid | 91.00 x 800 |
Ask | 131.50 x 900 |
Day's Range | 109.50 - 112.99 |
52 Week Range | 104.32 - 187.29 |
Volume | |
Avg. Volume | 438,973 |
Market Cap | N/A |
Beta (5Y Monthly) | 1.15 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | Apr 27, 2022 - May 02, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 163.38 |
Investors remain optimistic about DaVita (DVA) due to strength in its DaVita Kidney Care and impressive overseas growth.
Catalent's (CTLT) latest launch is expected to provide a reliable, reproducible and scalable path to clinic to its customers.
NextGen Healthcare's (NXGN) fiscal fourth-quarter earnings reflect strength in its Recurring revenues.